Humana Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Encouraged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / November 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Humana Inc. ("Humana" or "the Company") (NYSE:HUM) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
NEW YORK, NY / ACCESSWIRE / October 31, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
NEW YORK, NY / ACCESSWIRE / October 31, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Humana Q3 Earnings Beat on Growing Premiums & Cost Management
Better-than-expected Medicare Advantage membership aids HUM's third-quarter results.
Humana Inc. (HUM) Q3 2024 Earnings Call Transcript
Humana Inc. (NYSE:HUM ) Q3 2024 Earnings Conference Call October 30, 2024 9:00 AM ET Company Participants Lisa Stoner - VP, IR James Rechtin - President and CEO Susan Diamond - CFO George Renaudin - President, Insurance Conference Call Participants Justin Lake - Wolfe Research Ann Hynes - Mizuho Andrew Mok - Barclays Ben Hendrix - RBC Capital Markets Sarah James - Cantor Fitzgerald Joshua Raskin - Nephron Research Stephen Baxter - Wells Fargo Joanna Gajuk - Bank of America George Hill - Deutsche Bank Whit Mayo - Leerink Partners A.J. Rice - UBS David Windley - Jefferies Michael Ho - Baird Operator Good day and thank you for standing by.
Humana updates profit guidance as Q3 results top estimates
Humana (NYSE:HUM), a for-profit American health insurance firm, reported a beat on the top and bottom lines for the third quarter and strengthened its full year profit guidance, sending its shares higher on Wednesday. Revenue for Q3 was $29.3 billion, topping estimates of $28.7 billion.
Compared to Estimates, Humana (HUM) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Humana (HUM) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Humana (HUM) Q3 Earnings and Revenues Beat Estimates
Humana (HUM) came out with quarterly earnings of $4.16 per share, beating the Zacks Consensus Estimate of $3.48 per share. This compares to earnings of $7.78 per share a year ago.
Humana's earnings boosted as Medicare Advantage membership exceeds expectations
The health insurer still sees full-year adjusted per-share earnings of at least $16.
Humana beats quarterly profit estimates
Humana beat Wall Street estimates for third-quarter profit on Wednesday, helped by strength in its government-backed Medicare Advantage insurance business for older adults.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
NEW YORK, NY / ACCESSWIRE / October 29, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Humana's Payouts Will Get a Hard Look. Why the Election Matters More Than Earnings.
The health insurer's third-quarter report comes Wednesday. The numbers will show the growing problems with Medicare Advantage.
